Yoshiya Monden

530 total citations
8 papers, 446 citations indexed

About

Yoshiya Monden is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Yoshiya Monden has authored 8 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Cancer Research. Recurrent topics in Yoshiya Monden's work include Signaling Pathways in Disease (6 papers), Cardiac Fibrosis and Remodeling (6 papers) and NF-κB Signaling Pathways (4 papers). Yoshiya Monden is often cited by papers focused on Signaling Pathways in Disease (6 papers), Cardiac Fibrosis and Remodeling (6 papers) and NF-κB Signaling Pathways (4 papers). Yoshiya Monden collaborates with scholars based in Japan and United States. Yoshiya Monden's co-authors include Kenji Sunagawa, Hiroyuki Tsutsui, Natsumi Kawamura, Toru Kubota, Takahiro Inoue, Takaki Tsutsumi, Shin Kawano, Akira Takeshita, Tomomi Ide and Arthur M. Feldman and has published in prestigious journals such as Circulation, Cardiovascular Research and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Yoshiya Monden

8 papers receiving 440 citations

Peers

Yoshiya Monden
Anna Adamek Germany
Melissa Van Arsdall United States
Fujun Shi China
Jianqin Wei United States
Anna Adamek Germany
Yoshiya Monden
Citations per year, relative to Yoshiya Monden Yoshiya Monden (= 1×) peers Anna Adamek

Countries citing papers authored by Yoshiya Monden

Since Specialization
Citations

This map shows the geographic impact of Yoshiya Monden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiya Monden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiya Monden more than expected).

Fields of papers citing papers by Yoshiya Monden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiya Monden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiya Monden. The network helps show where Yoshiya Monden may publish in the future.

Co-authorship network of co-authors of Yoshiya Monden

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiya Monden. A scholar is included among the top collaborators of Yoshiya Monden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiya Monden. Yoshiya Monden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Monden, Yoshiya, Toru Kubota, Takahiro Inoue, et al.. (2007). Tumor necrosis factor-α is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology. 293(1). H743–H753. 113 indexed citations
2.
Inoue, Takahiro, Kensuke Egashira, Tomomi Ide, et al.. (2007). Abstract 434: A New Drug Delivery System Using Fibronectin-vegf Fusion Is More Effective And Harmless Than Vegf Alone For The Therapeutic Neovascularization. Circulation. 116(suppl_16). 1 indexed citations
3.
Monden, Yoshiya, Toru Kubota, Takaki Tsutsumi, et al.. (2006). Soluble TNF receptors prevent apoptosis in infiltrating cells and promote ventricular rupture and remodeling after myocardial infarction. Cardiovascular Research. 73(4). 794–805. 25 indexed citations
4.
Kubota, Toru, Yoshiya Monden, Takaki Tsutsumi, et al.. (2006). Blockade of NF-κB improves cardiac function and survival after myocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology. 291(3). H1337–H1344. 132 indexed citations
5.
Monden, Yoshiya, Toru Kubota, Takahiro Inoue, et al.. (2006). Tumor Necrosis Factor is Toxic Via Receptor 1 and Protective Via Receptor 2 in a Murine Model of Myocardial Infarction. Journal of Cardiac Failure. 12(8). S166–S166. 1 indexed citations
6.
Monden, Yoshiya, et al.. (2006). Tumor necrosis factor-α is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction. Journal of Molecular and Cellular Cardiology. 41(6). 1056–1056. 2 indexed citations
7.
Kawano, Shin, Yoshiya Monden, Natsumi Kawamura, et al.. (2005). Blockade of NF-κB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II. Cardiovascular Research. 67(4). 689–698. 87 indexed citations
8.
Kawamura, Natsumi, Shin Kawano, Yoshiya Monden, et al.. (2005). Blockade of NF-κB improves cardiac function and survival without affecting inflammation in TNF-α-induced cardiomyopathy. Cardiovascular Research. 66(3). 520–529. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026